Special Issues
Table of Content

Andrology and Sexual Medicine in the Modern Era: Challenges and Breakthroughs

Submission Deadline: 30 April 2026 (closed) View: 731 Submit to Journal

Guest Editor(s)

Prof. Zhang, Y

Email: zhxml@sina.com

Affiliation: Department of Infertility and Sexual medicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630 ,China 

Homepage:

Research Interests: andrology, evaluation and treatment of azoospermia, microsurgery techniques, erectile dysfunction, premature ejaculation

图片1.png


Dr. Karl H. Pang

Email: karlpang@doctors.org.uk

Affiliation: Division of Surgery and Interventional Science, University College London, London, UK; Department of Urology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK

Homepage:

Research Interests: andrology, sexual medicine, reproductive health, urological oncology

图片2.png


Summary

As male reproductive and sexual health faces increasing attention from both the medical community and the public, this collection of articles aims to address current challenges, showcase recent breakthroughs, and stimulate further interdisciplinary research and clinical innovation.

The aim of this Special Issue is to provide a comprehensive overview of the latest advances, ongoing challenges, and emerging trends in andrology and sexual medicine

Suggested themes:
· Erectile dysfunction and its emerging therapies
· Ejaculatory disorder (including premature, delayed, and painful ejaculation, POIS)
· Peyronie's disease and penile reconstruction
· Hypogonadism and testosterone therapy
· Sexual dysfunction related to prostate cancer treatment
· Sexual dysfunction related to penile cancer treatment
· Male infertility consideration in testicular cancer treatment
· Priapism
· Psychosexual aspects of male sexual dysfunction
· AI in sexual medicine
· Male infertility


Keywords

andrology, sexual medicine, penile prosthesis, peyronie's disease , premature ejaculation, erectile dysfunctionetc.

Published Papers


  • Open Access

    REVIEW

    Potential role of mirabegron in the treatment of erectile dysfunction: a narrative review

    Hang Gu, Yihan Shi, Xiancheng Du, Bo Zhang, Chunhui Liu, Ming Chen, Yuanji Shen, Chao Sun
    Canadian Journal of Urology, DOI:10.32604/cju.2026.085214
    (This article belongs to the Special Issue: Andrology and Sexual Medicine in the Modern Era: Challenges and Breakthroughs)
    Abstract Erectile dysfunction (ED) is a multifactorial disorder closely associated with vascular dysfunction, metabolic disease, impaired smooth muscle regulation, and aging-related changes. Although phosphodiesterase type 5 inhibitors (PDE5i) remain the cornerstone of pharmacological treatment, a substantial proportion of patients, particularly those with diabetes, endothelial dysfunction, or complex cardiometabolic comorbidities, show incomplete or inadequate responses. These limitations have encouraged growing interest in alternative pathways that regulate cavernosal smooth muscle tone beyond the classical nitric oxide–cyclic guanosine monophosphate axis. Mirabegron, a selective β3-adrenergic receptor agonist widely used for overactive bladder, has recently attracted attention as a potential repurposing candidate… More >

Share Link